BIOX Stock Analysis: Buy, Sell, or Hold?
BIOX - Bioceres Crop Solutions Corp. Ordinary Shares
$0.84
-0.13 (-13.46%)
▼
WAIT
LOW Confidence
Last Updated: January 30, 2026
Earnings: Feb 10, 2026
8d
Get Alerted When BIOX Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
⏸️ WAIT FOR STABILIZATION: BIOX is down 30.2% over the last 5 days. While fundamentals may be solid, catching a falling knife is risky. Wait for price to stabilize before entering.
⏸️ WAIT FOR STABILIZATION: BIOX is down 30.2% over the last 5 days. While fundamentals may be solid, catching a falling knife is risky. Wait for price to stabilize before entering.
In-depth Analysis How we analyze
Valuation Analysis: BIOX is currently trading at $0.84, which is considered oversold relative to its 30-day fair value range of $1.12 to $1.40. The stock's valuation (Forward PE: 16.8) is in line with its historical norms (17.5). Remarkably, the market is currently pricing in an annual earnings decline of 1.3% over the next few years. This pessimistic expectation contrasts with the company's recent 34.4% earnings growth, suggesting potential undervaluation if the company simply maintains stability.
Technical Outlook: Technically, BIOX is in a downtrend. The price is currently testing key support at $0.83. A bounce from this level would confirm strength, while a break below could signal further downside. Short-term momentum is weak, with the stock down 13.5% recently.
Market Sentiment: The stock shows a mixed technical setup (40/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $2.00 (+138.7%). Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, BIOX is in a downtrend. The price is currently testing key support at $0.83. A bounce from this level would confirm strength, while a break below could signal further downside. Short-term momentum is weak, with the stock down 13.5% recently.
Market Sentiment: The stock shows a mixed technical setup (40/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $2.00 (+138.7%). Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
OVERSOLD
Fair Price Range
$1.12 -
$1.40
Company Quality Score
44/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
74.8%
Protect Your Profits
Holding BIOX? Use our AI-powered strategies to protect your downside while keeping your long-term position.
View Profit Protection PlanAll Signals
- BULLISH: Price oversold vs 30-day range
- NEUTRAL: Mixed technical signals (40/100)
- BULLISH: High volume confirmation
- BEARISH: Downward momentum (-13.5%)
- BULLISH: Trading 138.7% below Wall St target ($2.00)
- WARNING: Recommendation downgraded due to -30.2% 5-day decline - wait for stabilization
Fair Price Analysis
30-Day Fair Range
$1.12 -
$1.40
Current vs Fair Value
OVERSOLD
Support & Resistance Levels
Support Level
$0.83
Resistance Level
$1.40
Current Trend
Downtrend
Fundamental Context
Forward P/E (Next Year Est.)
16.76
Wall Street Target
$2.00
(+138.7%)
Revenue Growth (YoY)
-16.4%
Earnings Growth (YoY)
34.4%
Profit Margin
-17.7%
Valuation Discount vs History
-1.3% cheaper
PE vs Historical
16.8 vs 17.5
FAIR
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
-1.3%
(market-implied from PE analysis)
1-Year Target
$0.83
(-1%)
2-Year Target
$0.82
(-3%)
3-Year Target
$0.81
(-4%)
3-Yr Target (if PE normalizes)
(PE: 17→18)
$0.84
(+0%)
💡
Upside Surprise Potential
If earnings stabilize (0% growth), PE could expand from 16.8 to 17.5
Stabilization Target:
$0.88
(+4.4%)
PE Expansion Potential:
+4.4%
Last updated: February 01, 2026 11:41 AM ET
Data refreshes hourly during market hours. Next update: 12:41 PM
Data refreshes hourly during market hours. Next update: 12:41 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is BIOX showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Featured in Portfolios
BIOX is a key holding in these high-performance investment strategies.
Top Rated Agricultural Inputs Stocks
Top-rated stocks in Agricultural Inputs by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
CTVA
Corteva Inc |
STRONG BUY
24 analysts |
$79 | 65 BUY |
|
NTR
Nutrien Ltd |
BUY
25 analysts |
$70 | 64 BUY |
|
MOS
The Mosaic Company |
BUY
20 analysts |
$32 | 64 BUY |
|
FMC
FMC Corporation |
HOLD
20 analysts |
$21 | 64 BUY |
|
SMG
Scotts Miracle-Gro Compa… |
STRONG BUY
11 analysts |
$72 | 56 HOLD |
Advanced BIOX Option Strategies
Professional options setups generated by AI based on today's BIOX price and gamma walls.
